Macrocyclic Agents Market: Increasing number of diagnostic procedures to drive the market

Contrast medium or diagnostic imaging agent is a substance that enhances the contrast of structures and fluids present inside the body in medical imaging. The widely used contrast mediums are generally based on gadolinium (Gd). Based on the chemical structure and chelating part, these gadolinium-based contrast mediums are categorized into linear and macrocyclic agents. The macromolecule with cyclic portion structure is referred as macrocyclic compound. Gadolinium-based macrocyclic compounds used as contrast medium are referred as macrocyclic agents. 

 Request Brochure of Report -

Gadolinium-based macrocyclic agents include gadobutrol and gadoteridol. There are two structurally different compounds available: open chain and cyclic chain. The open chain agents are also called linear agents. The gadolinium ion is captured into ligand cavity to produce macrocyclic agents. Owing to lesser degree of dissociation, macrocyclic agents are considered more stable than linear agents. Stability of macrocyclic agents depend on the degree of dissociation and how tightly the chelates are formed with the gadolinium ion. Macrocyclic agents have proven to be the most stable agents as these do not bind to serum proteins. The stable macrocyclic agents are recommended in pregnancy and lactating patients. Ideally, macrocyclic agents should have the following characteristics: selectivity for biochemical targets, good ratio of specific to nonspecific binding, better safety profile, and signal amplification capabilities. 

 Request for Analysis of COVID-19 Impact on Macrocyclic Agents Market –

Increasing number of diagnostic procedures and growing medical infrastructure are anticipated to drive the global macrocyclic agents market. Macrocyclic agents available in the market include Gadovist, ProHance, and Clariscan. Increase in the global use of gadolinium-based contrast agents is expected to fuel the growth of the global macrocyclic agents market. However, high costs are likely to hamper the growth of the global macrocyclic agents market. 

The global macrocyclic agents market has been segmented based on route of administration, procedure, application, and region. In terms of route of administration, the market has been segmented into oral, rectal, urethral, and parenteral. Increasing use of injectables in various procedures such as X-ray, CT scan, MRI, and ultrasound is expected to drive the global macrocyclic agents market. Based on procedure, the global macrocyclic agents market has been classified into X-ray, CT scan, MRI, and ultrasound. High number of approvals for MRI contrast media in various markets is one of the key factors driving the MRI segment. 

 Pre book Macrocyclic Agents Market Report at

Based on application, the global macrocyclic agents market has been divided into radiology, interventional cardiology, interventional radiology, and others. The radiology segment is estimated to hold the largest market share due to increasing number of diagnostic procedures. 

In terms of region, the global macrocyclic agents market has been segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is projected to hold the largest share of the global macrocyclic agents market during the forecast period. This is attributed to highly-developed medical infrastructure and increasing number of diagnostic procedures. Europe is expected to be the second largest market for macrocyclic agents. Rapidly developing countries such as India and China are anticipated to fuel the growth of the macrocyclic agents market in Asia Pacific. 

 Top of Form

 Ask for Discount :

Major players in the global macrocyclic agents market include GE Healthcare, Bayer AG, Bracco Imaging S.p.A., Daiichi Sankyo Company Limited, Eisai Co. Ltd., and Guerbet Group. Bayer AG and Bracco Imaging S.p.A. are expected to account for considerable share of the global macrocyclic agents market.

 About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453



Back to news